Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-806-2 | CAS number: 110-82-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 7-24 June 1981
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study, conducted to follow regulatory guidelines of the day and main current guideline points, fully adequate for assessment.
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 1 982
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Principles of method if other than guideline:
- The experimental methods used in this inhalation study are considered to be consistent with the main points of the OECD guideline No 475, for example, numbers of animals, cells scored, sampling times, cytogenetic parameters examined.
- GLP compliance:
- yes
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Cyclohexane
- EC Number:
- 203-806-2
- EC Name:
- Cyclohexane
- Cas Number:
- 110-82-7
- Molecular formula:
- C6H12
- IUPAC Name:
- cyclohexane
- Details on test material:
- Certified cyclohexane.
Clear colourless liquid
Lot 701739 Class 1B
99 Mol % pure
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: CRL:COBS CD(SD)BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 9 weeks (males), 14 weeks (females)
- Housing: Housed individually in suspended, wire-mesh, stainless steel cages.
- Diet: Purina "Certified Laboratory Chow 5002 ®" available ad libitum, except during exposures.
- Water: Acidified water ad libitum, except during exposures.
ENVIRONMENTAL CONDITIONS
- Temperature controlled
- Photoperiod: 12 hrs dark / 12 hrs light
Administration / exposure
- Route of administration:
- inhalation: vapour
- Vehicle:
- The concentrated cyclohexane vapour was diluted with room air in the chambers.
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
10 male and 10 female rats per group were dosed by inhalation exposure to cyclohexane vapour at analysed concentrations of 0, 96.6, 307.2 and 1041.6 ppm, for 6 hours/day for 5 days.
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
Stainless steel and plexiglass chambers of 0.25 cubic meter volume. The chambers were constructed with a square cross-sectional area and pyramidal tops and bases. The chambers were operated in a dynamic mode using room air to dilute the test material. The cyclohexane vapour was generated by bubbling dry, oil-free, breathing quality air through liquid cyclohexane in 250 or 500 ml gas wash bottles fitted with fritted glass cylinders. The control rats were placed in a chamber to which no test material was added. Animals were housed individually throughout the exposure periods.
Chamber temperature range: 24 - 27°C
Total airflow for all chambers was 28.3 litres per minute.
TEST ATMOSPHERE
The concentration of cyclohexane in the chamber atmospheres was determined at least hourly. - Duration of treatment / exposure:
- 6 hours/day
- Frequency of treatment:
- Daily for 5 days (Sunday - Thursday)
- Post exposure period:
- Bone marrow was sampled six hours after completion of the last exposure.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
Basis:
nominal conc.
0, 100, 300 and 1000 ppm
- Remarks:
- Doses / Concentrations:
Basis:
analytical conc.
0, 96.6, 307.2 and 1041.6 ppm
- No. of animals per sex per dose:
- 10 males / 10 females
- Control animals:
- yes, concurrent no treatment
- Positive control(s):
- Triethylenemelamine (TEM) at 10 mg/kg was the positive control substance and administered via a single intraperitoneal (IP) injection 24 hours prior to terminal kill.
Examinations
- Tissues and cell types examined:
- Bone marrow.
Routinely, 50 spreads were read for each animal. The locations of cells bearing aberrations were identified by the use of coordinates on the mechanical stage. A mitotic index based on at least 500 cells was also recorded. This index was calculated by scoring the number of cells in mitosis per 500 cells on each slide read. - Details of tissue and slide preparation:
- Three hours prior to kill with CO2, the animals were injected IP with 4.0 mg/kg of colchicine. The adhering soft tissue and epiphyses of both tibiae were removed according to the method of Legator et al., (1969). The marrow was flushed from the bone and transferred to Hanks' balanced salt solution. The marrow button was collected by centrifugation and then resuspended in 0.075M KCL. The centrifugation was repeated and the pellet resuspended in fixative (methanol:acetic acid, 3:1) The fixative was changed once and the cells were left overnight at 4°C. Cells in fixative were dropped onto glass slides and air-dried. Spreads were stained with 5% Giemsa at pH 6.8. After drying, the slides were cover-slipped. Slides were coded for control of bias and then scored for chromosomal aberrations. Standard forms were used to score and record gaps, breaks, fragments and reunion figures.
- Evaluation criteria:
- The test substance was tested to establish any interaction with chromosomes to produce gross lesions or changes in chromosome numbers and whether these are of a type which can survive more than one mitotic cycle of the cell. All aberration figures detected by this assay resulted from breaks in the chromatin which either failed to repair or repaired in atypical combination. The type of aberration, its frequency and its correlation to dose in a given time period were considered in the evaluation of mutagenic potential.
- Statistics:
- Statistical analysis employed a Student t-test (Bancroft, 1957)
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- There were no signs of toxicity in any rats during or after exposure.
Any other information on results incl. tables
Exposure conditions
|
Intended chamber concentration (ppm cyclohexane) |
|||
0 |
0 |
0 |
0 |
|
Mean chamber conc |
0±0 |
0±0 |
0±0 |
0±0 |
Chamber temp |
26.5±1.33 |
26.5±1.33 |
26.5±1.33 |
26.5±1.33 |
Number of samples |
40 |
40 |
40 |
40 |
Summary of results
Treatment |
Dose |
% cells with structural aberrations |
||
|
1 or more |
2 or more |
MI # |
|
Negative control |
N/A |
1.0 |
0 |
1.2 |
Positive control |
1.0 mg/kg |
73.4** |
66.9** |
0.1 |
Cyclohexane |
96.6 ppm |
0.7 |
0.3 |
3.1 |
|
307.2 ppm |
0.5 |
0.1 |
4.3 |
|
1041.6 ppm |
0* |
0 |
2.6 |
# Mitotic index based on at least 500 cells/animal *significant at<0.05 by t-test *significant at<0.01 by t-test |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Cyclohexane was negative in inducing chromosomal aberrations in rat bone marrow cells under the conditions of this assay. - Executive summary:
Groups of 10 male and 10 female Sprague Dawley rats were exposed by inhalation (6 hours each day for 5 days) to nominal doses of cyclohexane (99%, certified) of 96.6, 307.2 or 1041.6 ppm. Bone marrow was taken 6 hours after the last dose and cytogenetic examination made. The structural aberration frequency did not differ significantly from the negative control for any tested dose. The percentages of cells showing one or more structural aberrations or two or more structural aberrations were likewise similar to the negative controls. The results were the same whether males or females or both sexes pooled were evaluated by the Student t-test. A concurrent positive control substance, triethylenemelamine, showed a significant increase in structural aberration frequency compared with controls. Cyclohexane was not clastogenic toward rat bone under the conditions of this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.